期刊簡介預(yù)計審稿時間： 20 Weeks

PR&P is jointly published by the American Society for Pharmacology and Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS), and Wiley. PR&P is a bi-monthly open access journal that publishes a range of article types, including: target validation (preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development); drug discovery reviews (strategy, hypotheses, and data resulting in a successful therapeutic drug); frontiers in translational medicine (drug and target validation for an unmet therapeutic need); pharmacological hypotheses (reviews that are oriented to inform a novel hypothesis); and replication studies (work that refutes key findings [failed replication] and work that validates key findings). PR&P publishes papers submitted directly to the journal and those referred from the journals of ASPET and the BPS

PR&P 由美國藥理學(xué)和實驗治療學(xué)會 (ASPET)、英國藥理學(xué)學(xué)會 (BPS) 和 Wiley 聯(lián)合出版。PR&P 是一份雙月刊的開放獲取期刊，出版各種類型的文章，包括：靶標(biāo)驗證（表明假設(shè)不正確的臨床前論文或關(guān)于在早期臨床開發(fā)中失敗的藥物的論文）；藥物發(fā)現(xiàn)評論（導(dǎo)致成功治療藥物的策略、假設(shè)和數(shù)據(jù)）；轉(zhuǎn)化醫(yī)學(xué)前沿（針對未滿足的治療需求的藥物和靶標(biāo)驗證）；藥理學(xué)假設(shè)（旨在為新假設(shè)提供信息的評論）；以及復(fù)制研究（反駁關(guān)鍵發(fā)現(xiàn) [復(fù)制失敗] 的工作和驗證關(guān)鍵發(fā)現(xiàn)的工作）。PR&P 發(fā)表直接提交給期刊的論文以及 ASPET 和 BPS 期刊推薦的論文

《Pharmacology Research & Perspectives》(藥理學(xué)研究與展望)編輯部通訊方式為THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ。如果您需要協(xié)助投稿或潤稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對一投稿指導(dǎo)，避免您在投稿時頻繁碰壁，節(jié)省您的寶貴時間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內(nèi)容。